Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade
February 15, 2017 at 17:03 PM EST
The Vetr crowd downgraded their rating for ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) on Wednesday, from 4 stars (Buy), issued nine days ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.